IPO TABLE: Five biotech offerings coming soon after Affimed priced, eight others filed or set terms
This article was originally published in Scrip
Executive Summary
The market for initial public offerings has been especially frothy for biotechnology companies during the past two years and the week of 15 to 19 September may illustrate perfectly the strange dichotomy at work in the IPO space.